Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Assess the Nasopharyngeal Carriage of Streptococcus Pneumoniae (SPn), Long Term Safety and Immune Persistence in Healthy Kenyan PCV-Primed Toddlers (12-15 Months of Age) Who Received a Whole Cell Pneumococcal Vaccine (PATH-wSP) Compared to Controls

NCT02146365 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT02146365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02146365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Assess the Nasopharyngeal Carriage of Streptococcus Pneumoniae (SPn), Long Term Safety and Immune Persistence in Healthy Kenyan PCV-Primed Toddlers (12-15 Months of Age) Who Received a Whole Cell Pneumococcal Vaccine (PATH-wSP) Compared to Controls
Lead sponsor
PATH
Phase
Observational
Overall status
Completed
Start date
September 25, 2014
Completion date
February 18, 2016
Enrollment
297 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumococcal disease